Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Pietro Bulian, Riccardo Bomben, Michele Dal Bo, Antonella Zucchetto, Francesca Maria Rossi, Massimo Degan, Federico Pozzo, Tamara Bittolo, Vanessa Bravin, Tiziana D’Agaro, Michaela Cerri, Annalisa Chiarenza, Kari G. Chaffee, Adalgisa Condoluci, Giovanni D’Arena, Michele Spina, Francesco Zaja, Gabriele Pozzato, Francesco Di Raimondo, Davide RossiGiovanni Del Poeta, Gianluca Gaidano, Tait D. Shanafelt, Valter Gattei

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e443-e446
JournalHaematologica
Volume102
Issue number11
DOIs
Publication statusPublished - Oct 27 2017

ASJC Scopus subject areas

  • Hematology

Cite this

Bulian, P., Bomben, R., Dal Bo, M., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D’Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D’Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., ... Gattei, V. (2017). Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia. Haematologica, 102(11), e443-e446. https://doi.org/10.3324/haematol.2017.170340